PIERRE, S.D. –– American Cancer Society Cancer Action Network (ACS CAN) advocates will arrive at the Statehouse Wednesday for their annual Day at the Capitol.
The following is a statement from American Cancer Society Cancer Action Network (ACS CAN) New York Senior Government Relations Director Michael Davoli:
“Coming off Governor Hochul’s State of the State address earlier this week, where access to and the costs of health care were sparingly mentioned, patient advocates are hopeful that the governor prioritizes health care affordability in her executive budget proposal for FY 2025-26.
TALLAHASSEE, Florida – As Florida legislators begin committee meetings for the 2025 session, the American Cancer Society Cancer Action Network (ACS CAN) calls on them to prioritize reducing the cancer burden on Floridians.
CHEYENNE, Wyo. – As legislative business convenes today in the state capitol, lawmakers must prioritize access to health care so that tens of thousands of Wyomingites can continue to lead healthy and happy lives and have the best chance to avoid, detect and defeat cancer.
As Governor Daniel McKee prepares for his State of the State address, patient advocates are highlighting the results of a new report by the American Cancer Society Cancer Action Network (ACS CAN), which found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.
A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.
A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.
ATLANTA, Ga. – As Georgia lawmakers reconvene for the 2025 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) looks forward to working with them to prioritize legislation to ease the burden of cancer on Georgians.